drugset / Trial / NCT06871033

Ketamine Versus Neostigmine in Ultrasound-Guided Transversus Abdominis Plane Block in Caesarean Section

NCT06871033

Phase 3 Completed 80 enrolled Alexandria University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The current study investigates the efficacy and safety of ketamine and neostigmine as adjuvants in transversus abdominis plane blocks for Cesarean sections. The study participants arerandomized into two groups, each receiving either ketamine or neostigmine alongside plain bupivacaine. Various parameters, including pain intensity, intraoperative and postoperative hemodynamics, rescue analgesia requirements, patient satisfaction, and postoperative complications, are evaluated and compared between the two groups.

Timeline

Start
2024-01-01
Primary completion
2024-12-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Other
Subject Neostigmine Other / unclassified 500 ug Other
Background Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.